BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 19, 2020
View Archived Issues
Discovering pharmacological enzyme activators
Read More
ShanghaiTech University presents new estrogen receptor protein regulators
Read More
Clinical activity seen with bomedemstat in phase II study in advanced myelofibrosis
Read More
Positive topline phase II data for XP-3924 in type 1 diabetes mellitus
Read More
SETD2 as biomarker of overall survival in systemic mastocytosis
Read More
Novel humanized immunocompetent mouse model to study DCP-001 vaccine
Read More
Mutations in GBF1 associated with hereditary motor neuropathy
Read More
Merck & Co. discovers adenosine receptor A2A and/or A2B antagonists
Read More
Nimbus Lakshmi identifies new TYK2 inhibitors
Read More
Bristol-Myers Squibb patents FPR1/FPR2 agonists
Read More
New androgen and/or glucocorticoid receptor antagonists synthesized at Nuvation Bio
Read More
Phase I data presented for PF-06882961 in patients with type 2 diabetes
Read More
New peripheral 5-HT2A antagonists for NAFLD treatment by structural modification of pimavanserin
Read More
Neutralizing MAb from a convalescent patient inhibits SARS-CoV-2 infection in preclinical models
Read More
ZSCAN12 gene linked to congenital lower urinary tract obstruction
Read More
Innovent begins phase Ib/II trial of IBI-362 in overweight or obese subjects in China
Read More
Reistone begins dosing in phase II study of SHR-0302 for alopecia areata
Read More
Parkinson's findings have implications for models, targets, publications
Read More
FDA approves Crysvita for tumor-induced osteomalacia
Read More
Durvalumab/tremelimumab immunotherapy effective with chemotherapy in biliary tract cancer
Read More
FDA grants accelerated approval to Tazverik for relapsed/refractory follicular lymphoma
Read More
Loss-of-function mutation in CCDC134 gene tied to severe osteogenesis imperfecta
Read More
Amgen begins phase III trial with AMG-510 for NSCLC with KRAS p. G12c mutation
Read More
FXR agonist TERN-101 enters phase IIa study for NASH
Read More
Clover's COVID-19 vaccine candidate enters first-in-human study
Read More
First-in-human study evaluates GT-103 in refractory advanced NSCLC
Read More
